# Ultiva

NDC: 67457-913
Generic name: Remifentanil Hydrochloride
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200415

FDA application: NDA020630

## Active ingredients

- REMIFENTANIL HYDROCHLORIDE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-913"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-913
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dbcb8f9-1987-4b66-bd2f-d251fda0be10